title: MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma.
authors.affiliation: Department of Oncology, Transplants and Advanced Technologies, Section of Hematology, Pisa University, Pisa, Italy. ga.buda@libero.it
authors.forename: Gabriele
authors.initials: G
authors.lastname: Buda
authors.forename: Alessandro
authors.initials: A
authors.lastname: Martino
authors.forename: Valentina
authors.initials: V
authors.lastname: Maggini
authors.forename: Enrico
authors.initials: E
authors.lastname: Orciuolo
authors.forename: Sara
authors.initials: S
authors.lastname: Galimberti
authors.forename: Massimo
authors.initials: M
authors.lastname: Gentile
authors.forename: Fortunato
authors.initials: F
authors.lastname: Morabito
authors.forename: Federica
authors.initials: F
authors.lastname: Antognoni
authors.forename: Marino
authors.initials: M
authors.lastname: Brunori
authors.forename: Roberto
authors.initials: R
authors.lastname: Barale
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Rossi
authors.forename: Mario
authors.initials: M
authors.lastname: Petrini
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis; D011719:Pyrazines / Q000627:therapeutic use
chemical_list: C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib